Amkay Products Limited

Established in 2008, Amkay Products  manufacture, assemble & market a comprehensive portfolio of medical devices, disposables and other Healthcare Products like Face Mask, Alcohol Swabs, Lancet Needles, Nebulizer, Pulse Oximeter, surgeon cap etc. used by healthcare centres, hospitals/clinics, nursing homes etc. widely spread across India.The company’s product portfolio comprises of more than 30 product including Respiratory Disease Related Medical Devices, Surgical Disposables, Home Healthcare Products and Other Healthcare Products. Presently, they are manufacturing more than 20 products along with Branding & trading of more than 10 products. In addition, they are also engaged in branding and marketing of some of the products like Diapers, Plastic Gloves, Suction Machines etc.

The Company started its operations with manufacturing and supply of one product in a manufacturing unit taken on rent at Vasai in Mumbai, measuring 980 sq. feet. Gradually, more products were added to their portfolio & for further product expansion, They shifted to bigger manufacturing units from where they entered into branding & trading segment also along with manufacturing. They purchased a manufacturing unit at Acchad Industrial Area, Thane, measuring around 20,000 square feet.

Their manufacturing facilities are equipped with requisite infrastructure including machineries, testing laboratory and other handling equipment to facilitate smooth manufacturing process with total area of approx. 26000 sq. ft.The promoters are involved in the critical aspects of their business, including expansion, process and plant, finance, sales and marketing. Their understanding of the consumer difficulty, intuitive entrepreneurship and involvement in key aspects of their business has helped accelerate and drive our profitable growth. They believe that the sector-specific experience and expertise of their promoters has contributed significantly to the growth of the company.

Amkay Products Ltd Prepares for its Initial Public Offering (IPO), the proceeds generated from the Fresh Issue will be allocated towards crucial objectives: